Epidermal Growth Factor Receptor T790M Mutation Testing in Non-Small Cell Lung Cancer: An International Collaborative Study to Assess Molecular EGFR T790M Testing in Liquid Biopsy

Epidermal Growth Factor Receptor T790M Mutation Testing in Non-Small Cell Lung Cancer: An International Collaborative Study to Assess Molecular EGFR T790M Testing in Liquid Biopsy

Background: The detection of the EGFR T790M (T790M) mutation in non-small cell lung cancer (NSCLC) patients who progressed under treatment with first- or second-generation EGFR-tyrosine kinase inhibitors (TKIs) is important to offer a subsequent therapy with a third-generation EGFR-TKI. Liquid biops...

Full description

Bibliographic Details
Main Authors: Martin Filipits, Verena Kainz, Viktor Sebek, Herwig Zach, on behalf of the Liquid Biopsy Collaborative Study Group
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cancers
Subjects:
liquid biopsy
EGFR
NSCLC
T790M mutation
NGS
PCR
Online Access:https://www.mdpi.com/2072-6694/15/13/3528

Internet

https://www.mdpi.com/2072-6694/15/13/3528

Similar Items